MDClone Establishes Life Sciences Partnerships to Accelerate R&D Through Unparalleled Data Exploration
BEER-SHEVA, Israel, Aug. 2, 2023 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, announced today that in the last year it has established partnerships with multiple life sciences organizations to accelerate research and discovery processes through dynamic data exploration.
- BEER-SHEVA, Israel, Aug. 2, 2023 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, announced today that in the last year it has established partnerships with multiple life sciences organizations to accelerate research and discovery processes through dynamic data exploration.
- Via its Connect Platform, MDClone connects life science organizations to rich patient data needed to test hypotheses, build models, validate studies, develop clinical trials, improve care optimization, and create life-saving therapies.
- MDClone helps life sciences overcome these barriers by providing quick access to robust real-world data sets needed to answer complex healthcare questions.
- To learn more about how MDClone is reinventing life sciences innovation, click here .